Showing results (61-70 of 17,194) with videos related to
Sort By:
Pageof 1,720
Cancer Treatment Reports|February 1, 1985
Intracavitary cisplatin chemotherapy for mesotheliomaC E Pfeifle, S B Howell, M MarkmanCancer Chemotherapy and Pharmacology|January 1, 1981
Significance of variation in serum thymidine concentration for the marrow toxicity of methotrexateS B Howell, S J Mansfield, R TaetleAnticancer Research|November 1, 1994
In vivo modulation of cisplatin cytotoxicity by the cholecystokinin antagonist MK-329 in human pancreatic cancer xenograftsR Jamshidipour, E B Pinho, S B HowellAmerican Journal of Obstetrics and Gynecology|June 15, 1985
Intraperitoneal chemotherapy for advanced ovarian cancerW E Lucas, M Markman, S B HowellCancer Treatment Reports|October 1, 1982
Modulation of cytarabine metabolism in the human promyelocytic leukemia cell line HL-60 by polyhydroxy-substituted benzohydroxamic acidsS B Howell, S Gill, H L ElfordCancer Drug Delivery|January 1, 1984
Combination intracavitary chemotherapy for malignant pleural diseaseM Markman, S B Howell, M R GreenCancer Research|October 1, 1979
Activity of thymidine as a chemotherapeutic agent against human tumor xenografts in nude miceS B Howell, R S Jenkins, J StreifelThe Journal of Biological Chemistry|March 5, 1990
Increased sensitivity to cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells in response to treatment with 12-O-tetradecanoylphorbol 13-acetateS Isonishi, P A Andrews, S B HowellClinical Pharmacology and Therapeutics|March 1, 1984
Kinetics of sodium thiosulfate, a cisplatin neutralizerM Shea, J A Koziol, S B HowellCancer|July 15, 1994
A phase I trial of intraperitoneal carboplatin and etoposide with granulocyte macrophage colony stimulating factor support in patients with intraabdominal malignanciesE F McClay, P D Braly, S Kirmani, et al.Pageof 1,720